Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race

TY - JOUR

T1 - Diversity in Alzheimer's disease drug trials

T2 - Reflections on reporting and social construction of race

AU - Babulal, Ganesh M.

AU - Franzen, Sanne

AU - Abner, Erin L.

AU - Smith, Jade Emily

AU - van den Berg, Esther

AU - Mindt, Monica Rivera

AU - van Bruchem-Visser, Rozermarijn Lidewij

AU - Schneider, Lon S.

AU - Prins, Niels D.

AU - Papma, Janne M.

N1 - ACKNOWLEDGMENTS: F and JMP report a grant from The Netherlands Organisation forHealth Research and Development/Alzheimer’s Nederland (ZonMwMemorabel; grant number 733050834). JES reports a personalJamesB.Reynoldsscholarshipforforeignstudy.LSSreportsagrantfrom NIH (P30 AG066530). GMB reports grants from NIH/NIA(R01AG068183, R01AG067428, A2021142S) and the BrightFo-cus Foundation (A2021142S). MRM is supported by grants fromthe NIA/NIH (R13 AG071313-01, R01AG065110-01A1, NIH/NIA5U19AG024904-14, NIH/NIA R01AG066471-01A1), NIH/NIMH(U24MH100931-03), NIH/NIA (5R24AG065163), National ScienceFoundation,theGenentechHealthEquity2020Fund(G-89294),andtheAlzheimer’sAssociation(AARGD-16-446038).

PY - 2022/4

Y1 - 2022/4

UR - https://www.scopus.com/pages/publications/85124536992

U2 - 10.1002/alz.12611

DO - 10.1002/alz.12611

M3 - Article

C2 - 35142024

AN - SCOPUS:85124536992

SN - 1552-5260

VL - 18

SP - 867

EP - 868

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

IS - 4

ER -